Cutler Group LP Clearside Biomedical, Inc. Transaction History

Cutler Group LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 14, 2022	SELL	$1.35 - $2.88 $135 - $288	-100 Reduced 4.76%	2,000 $4,000
Q3 2021 Oct 26, 2021	SELL	$4.83 - $7.2 $6,762 - $10,080	-1,400 Reduced 40.0%	2,100 $12,000
Q2 2021 Jul 19, 2021	BUY	$2.32 - $5.38 $8,119 - $18,830	3,500 New	3,500 $17,000
Q3 2020 Oct 27, 2020	SELL	$1.45 - $2.0 $1,885 - $2,600	-1,300 Closed	0 $0
Q4 2018 Feb 05, 2019	BUY	$1.0 - $6.12 $1,300 - $7,956	1,300 New	1,300 $1,000
Q3 2018 Nov 07, 2018	SELL	$6.03 - $11.24 $39,195 - $73,060	-6,500 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$8.91 - $14.54 $49,896 - $81,424	5,600 Added 622.22%	6,500 $69,000
Q1 2018 May 11, 2018	BUY	$5.57 - $14.28 $5,013 - $12,852	900 New	900 $9,000

13.4M

17.6K

100

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $61.4M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.